Ekso Bionics Holdings Inc reports results for the quarter ended in June - Earnings Summary

Chronoscale

28/07/2022 22:02

* Ekso Bionics Holdings Inc  EKSO.OQ  reported a quarterly
adjusted loss of 23 cents​​ per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of 24 cents per share.
    * Revenue rose 56.7% to $3.47 million from a year ago;
analysts
expected $3.49 million. 
    * Ekso Bionics Holdings Inc's reported EPS for the quarter
was a
loss of 23 cents​.
    * The mean earnings estimate of analysts had risen by
about 41.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Ekso Bionics Holdings Inc shares had risen by 3.6% this
quarter and lost 35.5% so far this year.
    * The company reported a quarterly loss of $2.98 million.
    * Wall Street's median 12-month price target for Ekso
Bionics
Holdings Inc is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data July 28
at 09:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.24          -0.23          Beat
 Mar. 31 2022      -0.41          -0.36          Beat
 Dec. 31 2021      -0.25          -0.23          Beat
 Sep. 30 2021      -0.25          -0.15          Beat